About
The Cancer Focus Fund is an oncology-focused investment fund which invests in compelling cancer therapies at or near the FDA Phase 1 or Phase 2 human clinical trial regimen. The fund offers business, management, IP, clinical, scientific and regulatory support through experienced and proven professionals. At the Cancer Focus Fund, we invest in promising therapies in late preclinical development through Phase I and Phase Ib/II clinical trials.
Key facts
At-a-glance profile data
- Website
- cancerfocusfund.com
- Type
- Venture Capital
- Portfolio companies
- 2
- Stages
- Series B
- Cheque size
- $5M to $5M
- Sector focus
- Life SciencesImmunotherapyImmunologyCancerCancer Immunotherapy
Recent investments
Add first review
Frequently asked
What companies has Cancer Focus Fund invested in?
Cancer Focus Fund has invested in Starget Pharma, 178854, Nectin Therapeutics.

